No Data
No Data
TNF Pharmaceuticals Shares Are Trading Higher After the Company Announced That It Initiated the First in a Series of Studies to Evaluate the Impact of Isomyosamine.
TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | TNF Pharmaceuticals Completed FDA-Recommended Study Of Isomyosamine, Demonstrating Clinical Safety Throughout 13 Weeks Of Treatment At All Dose Levels Evaluated
TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
Express News | Tnf Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
Yog Sothoth : this thing has been dumping lol, looks like 48 was finally bottom for now